New York Genome Center Inc
- Assets
- $85.2m
- Revenue
- $72.3m
- Investments
- $0.0
- Employees
- 240
- Location
- New York, NY
- Founding
- 01/2012
- Data as of
- 12/2021
- EIN
- 80-0631734
Organization Overview
New York Genome Center Inc is located in New York, NY. The organization was established in 2012. According to its NTEE Classification (E22) the organization is classified as: General Hospitals, under the broad grouping of Health Care and related organizations. As of 12/2022, New York Genome Center Inc employed 240 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. New York Genome Center Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, New York Genome Center Inc generated $72.3m in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (1.4%) each year. All expenses for the organization totaled $69.1m during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (1.4%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, New York Genome Center Inc has awarded 67 individual grants totaling $8,797,160. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
ADVANCING GENOMIC RESEARCH TO DRIVE NOVEL BIOMEDICAL DISCOVERIES TO IMPROVE HUMAN HEALTH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
GENOME SEQUENCING: NYGC HAS ONE OF THE LARGEST VOLUME WHOLE GENOME SEQUENCING PROGRAMS IN NEW YORK. IN THE PAST SEVEN YEARS, NYGC'S SEQUENCING LABORATORY HAS SEQUENCED OVER 86,900 WHOLE GENOME SAMPLES. NYGC HAS FIVE NOVASEQ SYSTEMS SEQUENCERS, WITH THE CAPACITY TO SEQUENCE THOUSANDS OF GENOMES A YEAR. THIS STATE-OF-THE-ART SEQUENCING TECHNOLOGY ENABLES NYGC TO CONDUCT LARGE-SCALE GENOMICS PROJECTS WITH GREAT SPEED AND SAMPLE VOLUMES, AND TO EXPLORE THE GENOME IN MORE DEPTH WITH GREATER EFFICIENCY. SEE SCHEDULE O.
CLINICAL SEQUENCING: NYGC IS AUTHORIZED BY THE NEW YORK STATE DEPARTMENT OF HEALTH TO OFFER THE FOLLOWING APPROVED CLINICAL TESTS THROUGH ITS CLEP/CLIA CERTIFIED CLINICAL LABORATORY: CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR UNDIAGNOSED DISEASE, CONSTITUTIONAL WHOLEGENOME SEQUENCING FOR PREDISPOSITIONAL GENETIC SCREENING, ONCOLOGY WHOLE GENOME AND TRANSCRIPTOME SEQUENCING, CONSTITUTIONAL WHOLE EXOME SEQUENCING, TARGETED VARIANT TESTING USING SANGER SEQUENCING, ONCOLOGY WHOLE EXOME AND TRANSCRIPTOME SEQUENCING, AND THE SMASH GENOMIC ASSAY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Russell L Carson MBA Director & Chairman | OfficerTrustee | 1 | $0 |
Ivan G Seidenberg MBA Director & Co-Chair | OfficerTrustee | 1 | $0 |
Herb Pardes MD Director & Exec. Vice Chair | Trustee | 1 | $0 |
Gordon F Tomaselli MD Director | Trustee | 1 | $0 |
Bruce Stillman PHD Director | Trustee | 1 | $0 |
Anil Rustgi MD Director (thru 03/22) | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Donnelly Mechanical Engineering Services | 12/30/22 | $758,802 |
Guardian Services Industries Inc Cleaning Services | 12/30/22 | $365,998 |
Stonecourt 365 Holdings Llc Data Services | 12/30/22 | $231,313 |
Kpmg Llp Accounting Services | 12/30/22 | $164,350 |
Wayne Clarke Consulting Services | 12/30/22 | $149,042 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Total Revenue from Contributions, Gifts, Grants & Similar | $61,556,925 |
| Investment income | $27,107 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $1,251,014 |
| Net Rental Income | $202,966 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $72,299,111 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $166,389 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $5,255,579 |
| Compensation to disqualified persons | $185,902 |
| Other salaries and wages | $16,703,387 |
| Pension plan accruals and contributions | $1,123,438 |
| Other employee benefits | $2,096,930 |
| Payroll taxes | $2,035,272 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $235,238 |
| Fees for services: Accounting | $127,060 |
| Fees for services: Lobbying | $50,859 |
| Fees for services: Fundraising | $250 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $2,558,552 |
| Advertising and promotion | $0 |
| Office expenses | $314,627 |
| Information technology | $3,110,631 |
| Royalties | $395,340 |
| Occupancy | $14,120,934 |
| Travel | $67,457 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $37,508 |
| Interest | $268,263 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $5,665,542 |
| Insurance | $660,185 |
| All other expenses | $0 |
| Total functional expenses | $69,108,421 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $10,264,308 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $7,859,130 |
| Accounts receivable, net | $6,350,857 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $2,423,898 |
| Prepaid expenses and deferred charges | $3,304,280 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $7,552,563 |
| Total assets | $85,222,125 |
| Accounts payable and accrued expenses | $5,032,047 |
| Grants payable | $0 |
| Deferred revenue | $12,695,217 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $4,100,000 |
| Other liabilities | $24,252,205 |
| Total liabilities | $46,079,469 |
| Net assets without donor restrictions | $26,513,021 |
| Net assets with donor restrictions | $12,629,635 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Total liabilities and net assets/fund balances | $39,142,656 |
Grants Awarded
Over the last fiscal year, New York Genome Center Inc has awarded $2,108,827 in support to 13 organizations.
| Grant Recipient | Amount |
|---|---|
JOHNS HOPKIN UNIVERSITY PURPOSE: RESEARCH SUBAWARD | $258,161 |
COLUMBIA UNIVERSITY PURPOSE: RESEARCH SUBAWARD | $359,184 |
MEMORIAL SLOAN-KETTERING CANCER CENTER PURPOSE: RESEARCH SUBAWARD | $246,134 |
WEILL CORNELL MEDICAL COLLEGE PURPOSE: RESEARCH SUBAWARD | $212,435 |
YALE UNIVERSITY PURPOSE: RESEARCH SUBAWARD | $172,656 |
BROWN UNIVERSITY PURPOSE: RESEARCH SUBAWARD | $168,646 |